These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

771 related items for PubMed ID: 9278514

  • 1. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites.
    Paech K, Webb P, Kuiper GG, Nilsson S, Gustafsson J, Kushner PJ, Scanlan TS.
    Science; 1997 Sep 05; 277(5331):1508-10. PubMed ID: 9278514
    [Abstract] [Full Text] [Related]

  • 2. Suppression by estrogen receptor beta of AP-1 mediated transactivation through estrogen receptor alpha.
    Maruyama S, Fujimoto N, Asano K, Ito A.
    J Steroid Biochem Mol Biol; 2001 Aug 05; 78(2):177-84. PubMed ID: 11566442
    [Abstract] [Full Text] [Related]

  • 3. Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists.
    Barkhem T, Carlsson B, Nilsson Y, Enmark E, Gustafsson J, Nilsson S.
    Mol Pharmacol; 1998 Jul 05; 54(1):105-12. PubMed ID: 9658195
    [Abstract] [Full Text] [Related]

  • 4. The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens.
    Hall JM, McDonnell DP.
    Endocrinology; 1999 Dec 05; 140(12):5566-78. PubMed ID: 10579320
    [Abstract] [Full Text] [Related]

  • 5. Differential SERM activation of the estrogen receptors (ERalpha and ERbeta) at AP-1 sites.
    Weatherman RV, Clegg NJ, Scanlan TS.
    Chem Biol; 2001 May 05; 8(5):427-36. PubMed ID: 11358690
    [Abstract] [Full Text] [Related]

  • 6. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H, Ancelin M, Lardeux B, Milanini J, Perrot-Applanat M.
    Cancer Res; 2002 Sep 01; 62(17):4977-84. PubMed ID: 12208749
    [Abstract] [Full Text] [Related]

  • 7. Estradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors alpha and beta.
    Tee MK, Rogatsky I, Tzagarakis-Foster C, Cvoro A, An J, Christy RJ, Yamamoto KR, Leitman DC.
    Mol Biol Cell; 2004 Mar 01; 15(3):1262-72. PubMed ID: 14699072
    [Abstract] [Full Text] [Related]

  • 8. Estrogen receptor beta activates the human retinoic acid receptor alpha-1 promoter in response to tamoxifen and other estrogen receptor antagonists, but not in response to estrogen.
    Zou A, Marschke KB, Arnold KE, Berger EM, Fitzgerald P, Mais DE, Allegretto EA.
    Mol Endocrinol; 1999 Mar 01; 13(3):418-30. PubMed ID: 10076999
    [Abstract] [Full Text] [Related]

  • 9. Activity of a tamoxifen-raloxifene hybrid ligand for estrogen receptors at an AP-1 site.
    Weatherman RV, Carroll DC, Scanlan TS.
    Bioorg Med Chem Lett; 2001 Dec 17; 11(24):3129-31. PubMed ID: 11720858
    [Abstract] [Full Text] [Related]

  • 10. Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.
    Katzenellenbogen BS, Choi I, Delage-Mourroux R, Ediger TR, Martini PG, Montano M, Sun J, Weis K, Katzenellenbogen JA.
    J Steroid Biochem Mol Biol; 2000 Nov 30; 74(5):279-85. PubMed ID: 11162936
    [Abstract] [Full Text] [Related]

  • 11. Tamoxifen agonism and estrogen antagonism of c-fos gene promoter activity through non-consensus-responsive elements in MC3T3-E1 osteoblasts.
    Ishibashi O, Yamagishi T, Hanada K, Kawashima H.
    Biochem Biophys Res Commun; 2001 Dec 07; 289(3):705-11. PubMed ID: 11726205
    [Abstract] [Full Text] [Related]

  • 12. Endogenous estrogen receptor beta is transcriptionally active in primary ovarian cells from estrogen receptor knockout mice.
    Mueller SO, Katzenellenbogen JA, Korach KS.
    Steroids; 2004 Sep 07; 69(10):681-6. PubMed ID: 15465114
    [Abstract] [Full Text] [Related]

  • 13. Calmodulin is a selective modulator of estrogen receptors.
    García Pedrero JM, Del Rio B, Martínez-Campa C, Muramatsu M, Lazo PS, Ramos S.
    Mol Endocrinol; 2002 May 07; 16(5):947-60. PubMed ID: 11981030
    [Abstract] [Full Text] [Related]

  • 14. Stable transfection of an estrogen receptor beta cDNA isoform into MDA-MB-231 breast cancer cells.
    Tonetti DA, Rubenstein R, DeLeon M, Zhao H, Pappas SG, Bentrem DJ, Chen B, Constantinou A, Craig Jordan V.
    J Steroid Biochem Mol Biol; 2003 Oct 07; 87(1):47-55. PubMed ID: 14630090
    [Abstract] [Full Text] [Related]

  • 15. Domains of estrogen receptor alpha (ERalpha) required for ERalpha/Sp1-mediated activation of GC-rich promoters by estrogens and antiestrogens in breast cancer cells.
    Kim K, Thu N, Saville B, Safe S.
    Mol Endocrinol; 2003 May 07; 17(5):804-17. PubMed ID: 12576490
    [Abstract] [Full Text] [Related]

  • 16. Activities of estrogen receptor alpha- and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression.
    Harrington WR, Sheng S, Barnett DH, Petz LN, Katzenellenbogen JA, Katzenellenbogen BS.
    Mol Cell Endocrinol; 2003 Aug 29; 206(1-2):13-22. PubMed ID: 12943986
    [Abstract] [Full Text] [Related]

  • 17. Expression and role of estrogen receptor alpha and beta in medullary thyroid carcinoma: different roles in cancer growth and apoptosis.
    Cho MA, Lee MK, Nam KH, Chung WY, Park CS, Lee JH, Noh T, Yang WI, Rhee Y, Lim SK, Lee HC, Lee EJ.
    J Endocrinol; 2007 Nov 29; 195(2):255-63. PubMed ID: 17951536
    [Abstract] [Full Text] [Related]

  • 18. Effects of 4-hydroxytamoxifen, raloxifene and ICI 182 780 on survival of uterine cancer cell lines in the presence and absence of exogenous estrogens.
    Leblanc K, Sexton E, Parent S, Bélanger G, Déry MC, Boucher V, Asselin E.
    Int J Oncol; 2007 Feb 29; 30(2):477-87. PubMed ID: 17203231
    [Abstract] [Full Text] [Related]

  • 19. Estrogen receptor (ER)-mediated transcriptional regulation of the human corticotropin-releasing hormone-binding protein promoter: differential effects of ERalpha and ERbeta.
    van de Stolpe A, Slycke AJ, Reinders MO, Zomer AW, Goodenough S, Behl C, Seasholtz AF, van der Saag PT.
    Mol Endocrinol; 2004 Dec 29; 18(12):2908-23. PubMed ID: 15345745
    [Abstract] [Full Text] [Related]

  • 20. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
    Montano MM, Ekena K, Krueger KD, Keller AL, Katzenellenbogen BS.
    Mol Endocrinol; 1996 Mar 29; 10(3):230-42. PubMed ID: 8833652
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.